Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06580535 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Esterogen Receptor Modulator on Gene in Bipolar Diseas

Name: Effect of Esterogen Receptor Modulator on Gene in Bipolar Diseas — clinical trial record (NCT06580535)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusUnknown

PhaseNot specified

SponsorAssiut University

Started2024-09-05

View on ClinicalTrials.gov ↗

Record status

This record was last updated August 30, 2024 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.

1. Identify randomized controlled trials of tamoxifen (Estrogen Receptor modulator) in in addition to traditional treatment of bipolar disorder and synthesize the results using meta-analysis. 2. Systematically estimate the effects of Phospholipase C epsilon 1 gene (PLCE1) rs2274223and gene polymorphism on the susceptibility to treatment. 3. Study the pathway involved in the action of tamoxifen by incorporating TMX into nanoparticles and evaluating tyrosine kinase in responders WBCS culture and evaluate nanoparticle as a hope for future treatment of CNS disorders.

Amendment history 1 change detected by DataLookout

2026-09-06

Trial status changed: Not Yet Recruiting → Unknown

Trial Details

NCT Number	NCT06580535
Lead Sponsor	Assiut University
Conditions	Bipolar Disorder
Enrollment	100 participants
Start Date	2024-09-05
Primary Completion	2025-08 (estimated)
Study Completion	2025-12 (estimated)
Updated on ClinicalTrials.gov	2024-08-30